Ataxia-telangiectasia mutated (ATM) deficiency decreases reprogramming efficiency and leads to genomic instability in

Taisuke Kinoshita1, Go Nagamatsu, Takeo Kosaka

  • 1Department of Cell Differentiation, The Sakaguchi Laboratory, School of Medicine, Keio University, Tokyo 160-8582, Japan.

Insights

Ataxia-telangiectasia mutated (ATM) plays a role in somatic cell reprogramming, reducing efficiency but not preventing induced pluripotent stem cell (iPSC) generation. ATM-deficient iPSCs maintain pluripotency despite accumulating genomic abnormalities.

Area of Science:

  • Cell Biology
  • Genetics
  • Stem Cell Research

Background:

  • Somatic cell reprogramming to induced pluripotent stem cells (iPSCs) can expose cells to DNA damage.
  • The tumor suppressor gene p53's inactivation enhances reprogramming but increases chromosomal abnormalities.
  • Ataxia-telangiectasia mutated (ATM) is crucial for DNA double-strand break response and may influence reprogramming.

Purpose of the Study:

  • To investigate the function of ATM in the somatic cell reprogramming process.
  • To assess the impact of ATM deficiency on reprogramming efficiency and the characteristics of resulting iPSCs.

Main Methods:

  • Reprogramming of ATM-deficient (ATM-KO) tail-tip fibroblasts (TTFs).
  • Analysis of reprogramming efficiency, proliferation, gene expression, and differentiation capacity of ATM-KO iPSCs.
  • Karyotyping and assessment of genomic stability in ATM-KO iPSCs over passages.

Main Results:

  • Reprogramming efficiency was significantly reduced in ATM-KO TTFs.
  • ATM-KO iPSCs were successfully generated, exhibiting similar proliferation and gene expression profiles to wild-type (WT) iPSCs and embryonic stem (ES) cells.
  • ATM-KO iPSCs demonstrated differentiation potential into all three germ layers.
  • ATM-KO iPSCs accumulated abnormal genome structures with continuous passaging but retained pluripotency for at least 20 passages.

Conclusions:

  • ATM participates in somatic cell reprogramming, influencing efficiency.
  • ATM deficiency does not prevent the generation of functional iPSCs but leads to genomic instability over time.
  • The role of ATM in reprogramming is not essential for generating pluripotent stem cells.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...